Search Results - "Cheng, Zhaozhao"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Changes in CSF sPDGFRβ level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions by Lv, Xinyi, Zhang, Mengguo, Cheng, Zhaozhao, Wang, Qiong, Wang, Peng, Xie, Qiang, Ni, Ming, Shen, Yong, Tang, Qiqiang, Gao, Feng

    Published in Alzheimer's research & therapy (14-03-2023)
    “…CSF-soluble platelet-derived growth factor receptor beta (sPDGFRβ) is closely associated with pericyte damage. However, the changes in CSF sPDGFRβ levels and…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Correlation of blood-brain barrier leakage with cerebral small vessel disease including cerebral microbleeds in Alzheimer's disease by Cheng, Zhaozhao, Dai, Linbin, Wu, Yan, Cao, Yuqin, Chai, Xianliang, Wang, Peng, Liu, Chang, Ni, Ming, Gao, Feng, Wang, Qiong, Lv, Xinyi

    Published in Frontiers in neurology (16-02-2023)
    “…Blood-brain barrier (BBB) damage is considered an important part of Alzheimer's disease (AD) progression, and cerebral small-vessel disease (CSVD) is commonly…”
    Get full text
    Journal Article
  4. 4

    General anesthesia vs. non-general anesthesia for vertebrobasilar stroke endovascular therapy by Lu, Yanan, Xu, Pengfei, Wang, Jinjing, Xiao, Lulu, Zhang, Pan, Duan, Zuowei, Liu, Dezhi, Liu, Chaolai, Wang, Delong, Wang, Di, Zhang, Chao, Yao, Tao, Sun, Wen, Cheng, Zhaozhao, Li, Min

    Published in Frontiers in neurology (02-02-2023)
    “…The optimal type of anesthesia for acute vertebrobasilar artery occlusion (VBAO) remains controversial. We aimed to assess the influence of anesthetic…”
    Get full text
    Journal Article
  5. 5

    Identification of hub proteins in cerebrospinal fluid as potential biomarkers of Alzheimer’s disease by integrated bioinformatics by Li, Yang, Chen, Zuolong, Wang, Qiong, Lv, Xinyi, Cheng, Zhaozhao, Wu, Yan, Tang, Fang, Shen, Yong, Gao, Feng

    Published in Journal of neurology (01-03-2023)
    “…Background Alzheimer’s disease (AD) is a heterogeneous neurodegenerative disease with complex pathophysiology. Therefore, the identification of novel effective…”
    Get full text
    Journal Article
  6. 6

    High burdens of phosphorylated tau protein and distinct precuneus atrophy in sporadic early-onset Alzheimer’s disease by Lv, Xinyi, Cheng, Zhaozhao, Wang, Qiong, Gao, Feng, Dai, Linbin, Du, Chen, Liu, Chang, Xie, Qiang, Shen, Yong, Shi, Jiong

    Published in Science bulletin (30-11-2023)
    “…[Display omitted] Early-onset Alzheimer’s disease (EOAD) is a rare devastating subclassification of Alzheimer’s disease (AD). EOAD affects…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Molecules of senescent glial cells differentiate Alzheimer’s disease from ageing by Dai, Linbin, Gao, Feng, Wang, Qiong, Lv, Xinyi, Cheng, Zhaozhao, Wu, Yan, Chai, Xianliang, Zetterberg, Henrik, Blennow, Kaj, Levey, Allan I, Shi, Jiong, Shen, Yong

    “…BackgroundAgeing is a major risk factor for Alzheimer’s disease (AD), which is accompanied by cellular senescence and thousands of transcriptional changes in…”
    Get full text
    Journal Article
  10. 10

    Changes in CSF sPDGFR[beta] level and their association with blood-brain barrier breakdown in Alzheimer's disease with or without small cerebrovascular lesions by Lv, Xinyi, Zhang, Mengguo, Cheng, Zhaozhao, Wang, Qiong, Wang, Peng, Xie, Qiang, Ni, Ming, Shen, Yong, Tang, Qiqiang, Gao, Feng

    Published in Alzheimer's research & therapy (14-03-2023)
    “…Background CSF-soluble platelet-derived growth factor receptor beta (sPDGFR[beta]) is closely associated with pericyte damage. However, the changes in CSF…”
    Get full text
    Journal Article
  11. 11